Zimislecel, a novel cell therapy, appears to restore islet . . . Results from the phase 1 2 portion of the FORWARD-101 trial, which enrolled patients with type 1 diabetes with severe hypoglycemic events and impaired hypoglycemic awareness, were presented at the
Transplant treatment for diabetes shows promising results A completely new way of treating type 1 diabetes is being tested at Uppsala University Hospital Patients are being offered transplants of genetically modified insulin-producing cells and the initial results are promising
Mount Sinai Researchers Move Closer to a Cure for Diabetes Diabetes researchers and bioinformaticians from the Icahn School of Medicine at Mount Sinai have developed a new understanding of how human beta cell regenerative drugs work These drugs, developed at Mount Sinai, may hold promise for more than 500 million people with diabetes in the world
Son’s diabetes diagnosis sent scientist on quest for cure In 2019, the company was acquired by Vertex, and it now conducts clinical trials for people with Type 1 Melton said more than a dozen patients have completed the trial and “more than a handful” who have taken this new treatment are “insulin independent” — meaning they have not required additional exogenous insulin thus far
Diabetes Care Publishes Results From Prevalence Phase Of . . . Topline results were announced in December 2024, and complete results will be presented at the American Diabetes Association’s 85 th Scientific Sessions on June 23, 2025, at a symposium titled: “Treatment of Hypercortisolism in People with Difficult-to-Control Type 2 Diabetes – Final Results of the CATALYST Trial ”